Acute Leukemia News

  • FDA Approved Record Number of Drugs in 2018 The FDA approved 59 novel drugs last year, including 19 first-in-class agents, 34 novel drugs for rare diseases, and a record seven biosimilars.
  • Alert FDA Approves First-Ever Drug for Rare Cancer For the first time, the FDA has approved a drug for use specifically for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare disease with skin and leukemic involvement.

Acute Leukemia Perspective

  • NCI Director Promises New Directions to Accelerate Route to Cure Dr Norman Sharpless, director of the National Cancer Institute, provides an update on the progress of cancer research in the United States, and his goals for the future.
  • Top News From ASH 2018: Slideshow Hot topics include practice change data on chronic lymphocytic leukemia, validation of the durability of CAR T cells, and a new standard of care in myeloma.

Acute Leukemia Journal Articles